- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
MedX Health
Market Cap: CA$20.0m
Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally.
MDX
CA$0.07
7D
7.7%
1Y
-17.6%
Veri Medtech Holdings
Market Cap: US$14.3m
Provides health and wellness services and products through its healthcare technology platform.
VRHI
US$0.71
7D
34.4%
1Y
n/a
Edesa Biotech
Market Cap: US$14.3m
A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
EDSA
US$2.03
7D
-0.7%
1Y
-55.4%
Charlotte's Web Holdings
Market Cap: CA$19.8m
Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.
CWEB
CA$0.13
7D
8.7%
1Y
-50.0%
EOM Pharmaceuticals Holdings
Market Cap: US$14.2m
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.
IMUC
US$0.11
7D
6.3%
1Y
-43.8%
Nyrada
Market Cap: AU$22.1m
A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.
NYR
AU$0.10
7D
0%
1Y
61.5%
Unity Biotechnology
Market Cap: US$14.1m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UBX
US$0.82
7D
-10.3%
1Y
-44.6%
Lotus Pharmaceuticals
Market Cap: US$14.0m
Does not have significant operations.
LTUS
US$0.0053
7D
10.4%
1Y
12.2%
Ernexa Therapeutics
Market Cap: US$14.0m
A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.
ERNA
US$0.22
7D
12.2%
1Y
-88.8%
MEI Pharma
Market Cap: US$13.9m
A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
MEIP
US$2.08
7D
1.7%
1Y
-34.0%
Lifeward
Market Cap: US$13.8m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$1.30
7D
-5.1%
1Y
-74.3%
CardieX
Market Cap: AU$21.5m
Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
CDX
AU$0.053
7D
0%
1Y
-3.6%
GeoVax Labs
Market Cap: US$13.6m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.98
7D
6.2%
1Y
-42.1%
BiomX
Market Cap: US$13.5m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.54
7D
4.7%
1Y
-84.1%
Equillium
Market Cap: US$13.4m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
EQ
US$0.37
7D
-4.2%
1Y
-76.0%
Izotropic
Market Cap: CA$18.7m
A research and development company, develops diagnostic products for detecting breast cancers.
IZO
CA$0.29
7D
3.6%
1Y
123.1%
Conavi Medical
Market Cap: CA$18.6m
Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures.
CNVI
CA$0.42
7D
10.5%
1Y
n/a
OneMedNet
Market Cap: US$13.3m
A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.
ONMD
US$0.43
7D
5.4%
1Y
-7.1%
ModivCare
Market Cap: US$13.3m
A technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members in the United States.
MODV
US$0.92
7D
-21.0%
1Y
-96.6%
iBio
Market Cap: US$13.2m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.
IBIO
US$0.80
7D
3.4%
1Y
-59.6%
Orgenesis
Market Cap: US$13.2m
A biotech company, focuses on cell and gene therapies worldwide.
ORGS
US$2.01
7D
-3.4%
1Y
-63.6%
Moleculin Biotech
Market Cap: US$13.2m
A clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.
MBRX
US$0.94
7D
-10.5%
1Y
-81.5%
Aytu BioPharma
Market Cap: US$13.1m
A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.
AYTU
US$2.13
7D
70.4%
1Y
-27.6%
Noxopharm
Market Cap: AU$20.5m
A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.
NOX
AU$0.07
7D
-10.3%
1Y
-2.8%
Inspira Technologies Oxy B.H.N
Market Cap: US$13.0m
A specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
IINN
US$0.51
7D
-9.2%
1Y
-77.9%
Portage Biotech
Market Cap: US$13.0m
A clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.
PRTG
US$7.89
7D
-3.5%
1Y
54.0%
PharmaTher Holdings
Market Cap: CA$18.1m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.20
7D
-4.7%
1Y
-4.7%
Lumos Diagnostics Holdings
Market Cap: AU$20.2m
Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia.
LDX
AU$0.027
7D
0%
1Y
-41.3%
Ludwig Enterprises
Market Cap: US$12.9m
Operates as a genomic technology and health related company in the United States.
LUDG
US$0.08
7D
-11.1%
1Y
-63.6%
Synlogic
Market Cap: US$12.6m
A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.
SYBX
US$1.08
7D
-3.6%
1Y
-34.5%
Meihua International Medical Technologies
Market Cap: US$12.5m
Meihua International Medical Technologies Co., Ltd.
MHUA
US$0.39
7D
27.0%
1Y
-49.2%
BioCardia
Market Cap: US$12.4m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$2.44
7D
-14.4%
1Y
-58.5%
Biotricity
Market Cap: US$12.4m
A medical technology company, provides biometric data monitoring solutions in the United States.
BTCY
US$0.48
7D
-5.5%
1Y
-54.6%
NextCure
Market Cap: US$12.3m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$0.44
7D
-1.8%
1Y
-73.8%
Aspire Biopharma Holdings
Market Cap: US$12.2m
An early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States.
ASBP
US$0.25
7D
-30.2%
1Y
-97.9%
Enlitic
Market Cap: AU$19.0m
Operates in the healthcare sector in the United States, Europe, and Japan.
ENL
AU$0.033
7D
-14.5%
1Y
-91.9%